New blood test may detect fatty liver before It's too late

NCT ID NCT06225193

Recruiting now Diagnosis Sponsor: Methodist Health System Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at whether a blood test called the Enhanced Liver Fibrosis (ELF) test can find early signs of fatty liver disease in people who are at high risk, such as those with diabetes, high blood pressure, or heart disease. Researchers will review medical records of 300 adults to see how well the ELF test works compared to other methods like ultrasound or liver biopsy. The goal is to find a simpler way to catch liver problems early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a simpler, non-invasive blood test to catch fatty liver disease early in people at high risk.
What could go wrong: This is an early, retrospective study, not a treatment trial. The ELF test may not prove better than existing methods, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fatty liver disease metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FATTY LIVER

Contacts and locations

Locations

Methodist Dallas Medical Center
RECRUITING

Dallas, Texas, 75203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.